Ono Pharmaceutical Co., Ltd. (OPHLF)
OTCMKTS
· Delayed Price · Currency is USD
11.00
0.00 (0.00%)
Mar 11, 2025, 4:00 PM EST
Ono Pharmaceutical Revenue
Ono Pharmaceutical had revenue of 134.22B JPY in the quarter ending December 31, 2024, with 2.31% growth. This brings the company's revenue in the last twelve months to 487.33B, down -2.16% year-over-year. In the fiscal year ending March 31, 2024, Ono Pharmaceutical had annual revenue of 502.67B with 12.41% growth.
Revenue (ttm)
487.33B JPY
Revenue Growth
-2.16%
P/S Ratio
n/a
Revenue / Employee
126.48M JPY
Employees
3,853
Market Cap
5.34B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 502.67B | 55.49B | 12.41% |
Mar 31, 2023 | 447.19B | 85.83B | 23.75% |
Mar 31, 2022 | 361.36B | 52.08B | 16.84% |
Mar 31, 2021 | 309.28B | 16.86B | 5.77% |
Mar 31, 2020 | 292.42B | 3.79B | 1.31% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
SS Innovations International | 16.04M |
Veradigm | 1.53B |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
Silence Therapeutics | 43.26M |
BioStem Technologies | 210.49M |
Ono Pharmaceutical News
- 13 hours ago - Ionis out licenses blood disorder therapy to Ono in a deal worth up to $940M - Seeking Alpha
- 26 days ago - U.S. FDA Grants Full Approval of Deciphera's ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT) - Benzinga
- 5 weeks ago - Ono Pharmaceutical GAAP EPS of ¥162.87, revenue of ¥374.56B; reaffirms FY outlolok - Seeking Alpha
- 4 months ago - Ono Pharmaceutical reports Q2 results - Seeking Alpha
- 4 months ago - Equillium says Ono not acquiring itolizumab, stock craters 36% - Seeking Alpha
- 5 months ago - Kinaxis to Bolster Supply Chain Operations of Ono Pharmaceutical - Financial Post
- 5 months ago - Kinaxis to Bolster Supply Chain Operations of Ono Pharmaceutical - Business Wire
- 6 months ago - Turbine Achieves Key Milestone in Collaboration with Ono Pharmaceutical - Business Wire